Title:
ANTI-UBIQUITIN SYNTHETIC ANTIBODY
Document Type and Number:
WIPO Patent Application WO/2023/145861
Kind Code:
A1
Abstract:
The present invention is an anti-ubiquitin synthetic antibody including a fibronectin type III polypeptide monobody.
Inventors:
SAEKI YASUSHI (JP)
ENDO AKINORI (JP)
KAWASE YASUKO (JP)
MURAKAMI HIROSHI (JP)
HAYASHI GOSUKE (JP)
SUGIHARA ATSUSHI (JP)
FUKAI SHUYA (JP)
OKATSU KEI (JP)
ENDO AKINORI (JP)
KAWASE YASUKO (JP)
MURAKAMI HIROSHI (JP)
HAYASHI GOSUKE (JP)
SUGIHARA ATSUSHI (JP)
FUKAI SHUYA (JP)
OKATSU KEI (JP)
Application Number:
PCT/JP2023/002596
Publication Date:
August 03, 2023
Filing Date:
January 27, 2023
Export Citation:
Assignee:
TOKYO METROPOLITAN INST MEDICAL SCIENCE (JP)
NATIONAL UNIV CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (JP)
UNIV KYOTO (JP)
NATIONAL UNIV CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (JP)
UNIV KYOTO (JP)
International Classes:
C07K16/18; C07K14/78; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/13; C12N15/63; C12P21/08; G01N33/53
Foreign References:
JP2013539362A | 2013-10-24 |
Other References:
AKIKO KOIDE, CHARLES W BAILEY, XIAOLIN HUANG, SHOHEI KOIDE: "The fibronectin type III domain as a scaffold for novel binding proteins", JOURNAL OF MOLECULAR BIOLOGY, ACADEMIC PRESS, UNITED KINGDOM, vol. 284, no. 4, 11 December 1998 (1998-12-11), United Kingdom , pages 1141 - 1151, XP008153820, ISSN: 0022-2836, DOI: 10.1006/jmbi.1998.2238
D. LIPOVSEK: "Adnectins: engineered target-binding protein therapeutics", PROTEIN ENGINEERING, DESIGN AND SELECTION, OXFORD JOURNAL, LONDON, GB, vol. 24, no. 1-2, 1 January 2011 (2011-01-01), GB , pages 3 - 9, XP055551510, ISSN: 1741-0126, DOI: 10.1093/protein/gzq097
D. LIPOVSEK: "Adnectins: engineered target-binding protein therapeutics", PROTEIN ENGINEERING, DESIGN AND SELECTION, OXFORD JOURNAL, LONDON, GB, vol. 24, no. 1-2, 1 January 2011 (2011-01-01), GB , pages 3 - 9, XP055551510, ISSN: 1741-0126, DOI: 10.1093/protein/gzq097
Attorney, Agent or Firm:
KOBAYASHI Hiroshi et al. (JP)
Download PDF: